Fladrafinil was initially produced from the French pharmaceutical firm Lafon Laboratories during the 1970s as aspect of their study into wakefulness-promoting agents.Fladrafinil may possibly communicate with prescription drugs metabolized by CYP enzymes, mainly because it is thought to induce or inhibit these liver enzymes.Although Fladrafinil has